BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23019289)

  • 1. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.
    van Rheenen PF; Van de Vijver E; Fidler V
    BMJ; 2010 Jul; 341():c3369. PubMed ID: 20634346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
    Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
    Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
    Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
    Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
    Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
    Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.
    Heida A; Van de Vijver E; Muller Kobold A; van Rheenen P
    BMJ Open; 2017 May; 7(5):e015636. PubMed ID: 28554936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care.
    Pavlidis P; Chedgy FJ; Tibble JA
    Scand J Gastroenterol; 2013 Sep; 48(9):1048-54. PubMed ID: 23883068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study.
    Hasler S; Zahnd N; Müller S; Vavricka S; Rogler G; Tandjung R; Rosemann T
    BMJ Open; 2015 Mar; 5(3):e007306. PubMed ID: 25757949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
    Diamanti A; Panetta F; Basso MS; Forgione A; Colistro F; Bracci F; Papadatou B; Francalanci P; Torroni F; Knafelz D; Fina F; Castro M
    Inflamm Bowel Dis; 2010 Nov; 16(11):1926-30. PubMed ID: 20310017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A; Tighe MP; Batra A
    Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
    Akobeng AK
    Acta Paediatr; 2018 Nov; 107(11):2019-2023. PubMed ID: 29706011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
    Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.